Keyhole limpet hemocyanin induces the activation and maturation of human dendritic cells through the involvement of mannose receptor

Molecular Immunology

Volumn 45, Issue 4, 2008, Pages 1136-1145

  Presicce, Pietro ^a   Taddeo, Adriano ^a   Conti, Antonietta ^b   Villa, Maria Luisa ^a   Della Bella, Silvia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN CARLO BORROMEO HOSPITAL   (Italy)

Author keywords

Cytokines; Dendritic cells; Mannose receptor; T cells

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; KEYHOLE LIMPET HEMOCYANIN; MANNOSE RECEPTOR;

ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CELL MATURATION; CELL SURFACE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; IN VITRO STUDY; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; UPREGULATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; HEMOCYANIN; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-2; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; MONOCYTES; RECEPTORS, CELL SURFACE;

EID: 35548988466     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.07.020     Document Type: Article

References (49)

1. Ackerman A.L., Kyritsis C., Tampe R., and Cresswell P. Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells. Nat. Immunol. 6 (2005) 107-113
2. Aranami T., Iwabuchi K., and Onoé K. Singenyc mixed lymphocyte reaction (SMLR) with dendritic cells: direct visualization of dividing T cell subsets in SMLR. Cell. Immunol. 217 (2007) 67-77
3. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., and Palucka A.K. Immunobiology of dendritic cells. Ann. Rev. Immunol. 18 (2000) 767-811
4. Banchereau J., and Palucka A.K. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 5 (2005) 296-306
5. Bleumer I., Tiemessen D.M., Oosterwijk-Wakka J.C., Völler M.C., De Weijer K., Mulders P.F., and Oosterwijk E. Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cells. J. Immunother. 30 (2007) 116-122
6. Chieppa M., Bianchi G., Doni A., Del Prete A., Sironi M., Laskarin G., Monti P., Piemonti L., Biondi A., Mantovani A., Introna M., and Allavena P. Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. J. Immunol. 171 (2003) 4552-4560
7. Davis I.D., Jefford M., Parente P., and Cebon J. Rational approaches to human cancer immunoteraphy. J. Leukoc. Biol. 73 (2003) 3-29
8. Della Bella S., Biasin M., Clerici M., and Villa M.L. Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-α. J. Leukoc. Biol. 75 (2004) 106-116
9. Della Bella S., Clerici M., and Villa M.L. Disarming dendritic cells: a tumour strategy to escape from immune control?. Expert Rev. Clin. Immunol. 3 (2007) 411-422
10. Della Bella S., Gennaro M., Vaccari M., Ferrarsi C., Nicola S., Riva A., Clerici M., Greco M., and Villa M.L. Altered maturation of peripheral blood dendritic cells in patients with breast cancer. Br. J. Cancer 89 (2003) 1463-1472
11. Della Bella S., Nicola S., Brambilla L., Riva A., Ferrucci S., Presicce P., Boneschi V., Berti E., and Villa M.L. Quantitative and functional defects of dendritic cells in classic Kaposi's sarcoma. Clin. Immunol. 122 (2007) 220-228
12. Della Bella S., Nicola S., Timofeeva I., Villa M.L., Santoro A., and Berardi A.C. Are interleukin-16 and thrombopoietin new tools for the in vitro generation of dendritic cells?. Blood 104 (2004) 4020-4028
13. Dhodapkar M.V., Steinman R.M., Krasovsky J., Munz C., and Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193 (2001) 233-238
14. Engering A.J., Cella M., Fluitsma D., Brokhaus M., Hoefsmit E.C., Lanzavecchia A., and Pieters J. The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur. J. Immunol. 27 (1997) 2417-2425
15. Francois Bach J. Regulatory T cells under scrutiny. Nat. Rev. Immunol. 3 (2003) 189-198
16. Gabrilovich D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat. Rev. Immunol. 4 (2004) 941-952
17. Harris J.R., and Markl J. Keyhole limpet hemocyanin (KLH): a biomedical review. Micron 30 (1999) 597-623
18. + blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer. Lancet 352 (1998) 1358
19. Holtl L., Rieser C., Papesh C., Ramoner R., Herlord M., Klocker H., Radmayr C., Stenzl A., Bartsch G., and Thurnher M. Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. J. Urol. 161 (1999) 777-782
20. Jonuleit H., and Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. J. Immunol. 171 (2003) 6323-6327
21. Kaliński P., Hilkens C.M.U., Wierenga E.A., and Kapsenberg M.L. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 20 (1999) 561-567
22. Kugler A., Stuhler G., Walden P., Zöller G., Zobywalski A., Brossart P., Trefzer U., Ullrich S., Müller G.A., Becker V., and Ringert R.H. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat. Med. 6 (2000) 332-336
23. Lamm D.L., Deahven J.I., and Riggs D.R. Keyhole limpet hemocyanin immunotherapy of bladder cancer: laboratory and clinical studies. Eur. Urol. 3 (2000) 41-44
24. Levings M.K., Bacchetta R., Schulz U., and Roncarolo M.G. The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. Int. Arch. Allergy Immunol. 129 (2002) 263-276
25. Mansour M.K., Latz E., and Levitz S.M. Cryptococcus neoformans glycoantigens are captured by multiple lectin receptors and presented by dendritic cells. J. Immunol. 176 (2006) 3053-3061
26. + T-cell priming and help to peptide-specific cytotoxic T-cell response, in view of potential use in cancer vaccines. Vaccine 21 (2003) 869-876
27. Nabarro S., Thrasher A.J., Kempski H., Amrolia P., and Anderson J. Generation of immunostimulatory denditic cells from the malignant clone in patients with juvenile myelomonocytic leukaemia. Leukemia 17 (2003) 1910-1912
28. Nigou J., Zelle-Rieser C., Gilleron M., Thurnher M., and Puzo G. Mannosylated Lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J. Immunol. (2001) 7477-7485
29. O'Neill D.W., Adams S., and Bhardwaj N. Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood 104 (2004) 2235-2246
30. Oosterwijk-Wakka J.C., Tiemessen D.M., Bleumer I., deVries J.M., Jongmans W., Adema G.J., Debruyne F.M.J., de Mulder P.H., Oosterwijk E., and Mulders P.F. Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 study. J. Immunother. 25 (2002) 500-508
31. Orlova E.V., Dube P., Harris J.R., Beckam E., Zemlin F., Markl J., and van Heel M. Structure of keyhole limpet hemocyanin type 1 (KLH1) at 15 A resolution by electron cryomicroscopy and angular reconstitution. J. Mol. Biol. 271 (1997) 417-437
32. Orsini E., Guarini A., Chiaretti S., Mauro F.R., and Foa R. The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response. Cancer Res. 63 (2003) 4497-4506
33. Pietrella D., Corbucci C., Perito S., Bistoni G., and Vecchierelli A. Mannoproteins from Cryptococcus neoformans promote dendritic cell maturation and activation. Infect. Imm. 73 (2005) 820-827
34. Ratta M., Fagnoni F., Curti A., Vescovini R., Sansoni P., Oliviero B., Fogli M., Ferri E., Della Cuna G.R., Tura S., Baccarani M., and Lemoli R.M. Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6. Blood 100 (2002) 231-237
35. Reis E., and Sousa C. Dendritic cells in a mature age. Nat. Rev. Immunol. 6 (2006) 476-483
36. Riggs R.D., Jackson B.J., Vona-Davis L., Nigam A., and McFadden D.W. In vitro effects of keyhole limpet hemocyanin in breast and pancreatic cancer in regards to cell growth, cytokine production, and apoptosis. Am. J. Surg. 189 (2005) 680-684
37. Riggs R.D., Jackson B.J., Vona-Davis, and McFadden D.W. In vitro anticancer effects of a novel immunostimulant: keyhole limpet hemocyanin. J. Surg. Res. 108 (2002) 279-284
38. Rissoan M.C., Soumelis V., Kadowaki N., Grouard G., Briere F., de Waal Malefyt R., and Liu Y.J. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283 (1999) 1183-1186
39. Skoberne M., Beignon A.S., and Bhardway N. Danger signals: a time and space continuum. Trends Mol. Med. 10 (2004) 251-257
40. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9 (1991) 271-296
41. Stoeva S., Schutz J., Gebauer W., Hundsdorfer T., Manz C., Markl J., and Voelter W. Primary structure and unusual carbohydrate moiety of functional unit 2-c of keyhole limpet hemocyanin (KLH). Biochim. Biophys. Acta 16 (1999) 94-109
42. Swerdlow R.D., Ratliff T.L., La Regina M., Ritchey J.K., and Ebert R.F. Immunotherapy with keyhole limpet hemocyan: efficacy and safety in the MB-49 intravesical murine bladder tumor model. J. Urol. 151 (1994) 1718-1722
43. Tan M.C., Mommaas A.M., Drijfhout J.W., Jordens R., Onderwater J.J., Verwoerd D., Mulder A.A., van der Heiden A.N., Scheidegger D., Oomen L.C., Ottenhoff T.H., Tulp A., Neefjes J.J., and Koning F. Mannose receptor-mediated uptake of antigens strongly enhanced HLA class II-restricted antigen presentation by cultured dendritic cells. Eur. J. Immunol. 27 (1997) 2426-2435
44. Thurnher M., Rieser C., Holtl L., Papesh C., Ramoner R., and Bartsch G. Dendritic-cell based immunotherapy of renal cell carcinoma. Urol. Int. 61 (1998) 67-71
45. Van Kuik J.A., Kamerling J.P., and Vliegenthart J.F.G. Carbohydrate analysis of hemocyanins. In: Preaux G., and Lontie R. (Eds). Invertebrate Oxygen Carriers (1990), Leuven University Press, Leuven 157-163
46. Wirguin I., Suturkova Milosevic L., Briani C., and Latov N. Keyhole limpet hemocyanin contains Gal(β 1-3)-GalNAc determinants that are cross-reactive with the T antigen. Cancer Immunol. Immunother. 40 (1995) 307-310
47. + regulatory T cells by dendritic cells during the mixed leucocyte reaction. PNAS 103 (2006) 2758-2763
48. Yang L., and Carbone D.P. Tumor-host immune interactions and dendritic cells dysfunction. Adv. Cancer Res. 92 (2004) 13-27
49. Zhang S.L., Graeber L.A., Helling F., Ragupathi G., Adluri S., Lloyd K.O., and Livingston P.O. Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice. Cancer Res. 56 (1996) 3315-3319